✦ LIBER ✦

998 A phase II study of a novel taxane BAY 59-8862 in patients with aggressive refractory non-Hodgkin's lymphoma

✍ Scribed by R. Turner; A. Delmer; T. Gentile; P. Sonneveld; D. Vesole; S. Turri; F. Barouki; S. Coppieters

Book ID: 118621162
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 167 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)91025-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of darinapa

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

✍ Peter J. Hosein; Michael D. Craig; Martin S. Tallman; Ralph V. Boccia; Brian L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

ABVD: doxorubicin,

A phase II study of Xcellerated T cells™

A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)

✍ J.G. Gribben; N.L. Bartlett; J.J. Stephenson; M.S. Milder; R.V. Boccia; C. Redfe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A phase II trial of bryostatin 1 in pati

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma

✍ Ranson, M; Radford, J A; Hancock, B W; Soukop, M; McGown, A T; Robbins, A; Halbe 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

Fourteen-Day CHOP Supported with Granulo

Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma: Results of a Phase II Study

✍ Gregory, Stephanie A.; Case, Delvyn C.; Bosserman, Linda; Litwak, Debra L.; Berr 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

A multicenter phase II trial of etoposid

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma

✍ Sun Jin Sym; Dae Ho Lee; Hye Jin Kang; Seung Hyun Nam; Ho Young Kim; Seok Jin Ki 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 292 KB

Bendamustine in Patients With Rituximab-

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

✍ Friedberg, J. W.; Cohen, P.; Chen, L.; Robinson, K. S.; Forero-Torres, A.; La Ca 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 118 KB